Company: ICUI
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000883984-25-000010
Chunk: 3

Company: ICU MEDICAL INC/DE
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 3
---
 Directors (the “Board”) of the Company of proxies to be voted at the 2025 Annual Meeting of Stockholders of the Company (the “Annual Meeting”) and at any continuation, adjournment or postponement thereof, for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. First person pronouns used in this Proxy Statement, such as “we,” “us,” and “our,” refer to ICU and its subsidiaries unless context requires otherwise.

This Proxy Statement and the Company's Annual Report for the year ended December 31, 2024 (the “2024 Annual Report”) are being made available to stockholders on or about April 3, 2025.

#### Annual Meeting of Stockholders

#### Time and Date
The Annual Meeting will be held virtually on Tuesday, May 13, 2025 at 9 a.m. Pacific Time (“PT”). Stockholders may attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/ICUI2025 .

#### Record Date
The Board has set March 20, 2025 as the record date (the “Record Date”) for the Annual Meeting. If you were a stockholder of record at the close of business on the record date, then you are entitled to receive notice of, and to vote at, the Annual Meeting.

As of March 20, 2025, the outstanding voting securities of the Company consisted of 24,610,150 shares of $0.10 par value common stock (the “Common Stock”).

#### Voting
Each stockholder of record at the close of business on the Record Date is entitled to one vote for each share held as of that date on each matter submitted to a vote of stockholders. The presence in person or by proxy of holders of a majority of the outstanding shares of stock entitled to vote at the meeting will constitute a quorum for the transaction of such business as shall properly come before the Annual Meeting. There are no cumulative voting rights.

#### Voting Matters
• Elect the seven director nominees named in this Proxy Statement.

• Approve an amendment to the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan.

• Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2025.

• Advisory vote to approve executive compensation paid to our named executive officers.

• Advisory vote on a stockholder proposal to adopt simple majority voting.

• To transact such other business as may properly come before the